Armenia vs Israel: The number of people with susceptibility test result for rifampicin
Armenia
100
in 2021
Israel
100
in 2021
Armenia rank
2nd
Israel rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Armenia
- Israel
How they compare
Armenia currently reports 100 against 100 in Israel, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Israel ahead.
Armenia ranks 2nd and Israel ranks 2nd of 146 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.02 | 98.2 | 0.1735 | Israel |
| 2020s | 99.75 | 100 | 0.2512 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Armenia or Israel?
- Armenia, at 100 against 100 in Israel as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Armenia and Israel?
- 0, with Armenia ahead.
- How many years of comparable data are there for Armenia and Israel?
- 5 years are reported by both, from 2017 to 2021.
- How do Armenia and Israel rank globally for the number of people with susceptibility test result for rifampicin?
- Armenia ranks 2nd and Israel ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.